Evidence map›Paper›PMID 37711674›Full record

ArticleHealth science reports2023

Machine learning model of imipenem-resistant

Yu Zeng, Chao Wang, Qing Ye, Gang Liu, Lixia Zhang, Jingjing Wan, Yu Zhu

Abstract read
In one paragraph

Article in Health science reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Public Transcriptomic Data Mining for SCLC: From Candidate Ma rkers to Therapeutic Exploration.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Machine learning model of imipenem-resistantHealth science reports · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yu ZengSchool of Chemistry and Molecular Engineering East China Normal University Shanghai China.
Chao WangDepartment of Clinical Laboratory First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Tianjin China.
Qing YeDepartment of Hepatology The Third Central Hospital of Tianjin Tianjin China.
Gang LiuDepartment of Clinical Laboratory Tianjin Haihe Hospital Tianjin China.
Lixia ZhangDepartment of Clinical Laboratory Tianjin Haihe Hospital Tianjin China.
Jingjing WanSchool of Chemistry and Molecular Engineering East China Normal University Shanghai China.
Yu ZhuDepartment of Clinical Laboratory The Third Central Hospital of Tianjin Tianjin China.ORCID 0000-0003-0499-0235

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: Machine learning is an important branch and supporting technology of artificial intelligence, we established four machine learning model for the drug sensitivity of Methods: The data of MALDI-TOF-MS and imipenem sensitivity of 174 cases of Results: The R²Y and Q² of OPLS-DA were 0.546 and 0.0178. The AUC of the best training set and test set models were 0.9726 and 0.9100, 1.0000 and 0.8581, 0.8462 and 0.6263, 1.0000 and 0.7180 evaluated by LASSO, LR, SVM and NN model respectively. The accuracy of the LASSO, LR, SVM and NN model were 87%, 79%, 62%, and 68% in test set, respectively. Conclusion: The LASSO prediction model of

Indexed as

artificial intelligenceimipenemKlebsiella pneumoniaemachine learning

Identifiers

PMID37711674
PMCPMC10497903

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.